Peptides DB
Research-centric peptide and protocol reference hub

5-amino-1MQ record · updated 6h ago

Metabolic & appetiteMuscle & body compGrade A · human clinicalResearch use only
All 15 studiesJump to the evidenceCompare
What is 5-amino-1MQ used for?

Research-peptide often discussed for body recomposition: weight-loss–focused with muscle preservation, cholesterol and inflammation effects.

Primarily researched for · Metabolic & appetite

Development stage

where 5-amino-1MQ sits between preclinical work and regulatory approval
  1. 1Cleared
    Preclinical
    Animal / in-vitro work
  2. 2Cleared
    Phase 1
    Safety in humans
  3. 3Current
    Phase 2
    Efficacy signal
  4. 4Not reached
    Phase 3
    Confirmatory trials
  5. 5Not reached
    Approved
    Cleared by a regulator

Stage is inferred from the highest trial phase in the indexed corpus and 107 registered trials. It describes the research record, not a recommendation.

Identity
Name5-amino-1MQ
Chain length—
Molecular weight—
Formula—
Structure type—
ClassMetabolic
Research levelPreclinical
Discovered byAdded before provenance tracking · 2025
Pharmacology
Mechanism—
Route—
Half-life—
Time to peak—
Duration—
Extraction confidence—
Effect profile · 0–5
These seven scores are generated by the Librarian — an autonomous agent running GPT-4o over the indexed studies, trials and label data for this compound. No human assigns them and no community vote moves them. Last recomputed Sep 4, 2026. How this works →
Research stats
Total studies15
Human / animal / cellular8 / 4 / 2
Highest trial phasePhase 2
Years covered2010–2026
Latest study17d ago
Publication history
20102026
Research funding
607,412 NIH projects · $27.7M awarded · through FY2026
Public grants naming this compound. Funding is interest, not evidence.
Safety signals
FAERS reportsnone recorded
Serious AEs in animal work—
Community reports—
Positive —Neutral —Negative —
Records

Study register

15 rows · newest 12 shownOpen in the library →
StudyTypeYearSummary depth
Population genomics reveals a long-term increase in azole resistance associated with the emerging cluster AZR among <i>Candida tropicalis</i> causing invasive infections.
Finding42.3% fluconazole resistance rate among 911 C. tropicalis isolates, n=911.
Human2026Full text read0.80
Prevalence of antimicrobial-resistant <i>Escherichia coli</i> as an indicator bacterium in livestock and companion animals in Mongolia.
Finding93.9% of E. coli isolates from chickens were AMR.
Animal2026Full text read0.70
Dissecting the effect of long-term exposure to air pollution on risk of dementia in UK Biobank.
FindingHR=1.06 (1.02-1.11) per 9.86 µg/m³ interquartile range of NO₂ exposure.
Human2025Full text read0.80
Integrative metabolomic and transcriptomic analysis reveals stage-specific shifts in hepatic lipid metabolism of broiler chickens.
Finding1121 metabolites identified.
Animal2026Full text read0.80
The association between serum indoxyl sulfate and radial-cephalic arteriovenous fistulas dysfunction in ESKD patients: a prospective study.
FindingAUC = 0.87 for the 1-year patency nomogram.
Human2026Full text read0.80
Accelerated mutator phenotype in a clinical <i>Aspergillus fumigatus</i> isolate contributes to adaptive evolution.
FindingMutation frequency was approximately 15-times higher than other A. fumigatus strains.
Human2026Full text read0.80
Internet Cognitive Therapy for Prolonged Grief Disorder (iCT-PG): a developmental case series.
Finding87.5% (7/8) demonstrated reliable improvement in PGD symptoms on the Reliable Change Index at post-treatment.
Human2026Full text read0.80
Emotion regulation skills training as an adjunctive treatment to narrative exposure therapy for posttraumatic stress disorder (PTSD) in refugees: a pilot randomized controlled trial.
Findingg=-1.54 for SPS+NET, p<0.001 at 3-month follow-up for clinician-assessed PTSD symptoms.
Human2026Full text read0.80
The impact of nonpharmaceutical interventions (NPIs) on rabies post-exposure prophylaxis: A comparative study in Wuhan, 2022 vs. 2023.
Finding33.17% category III exposures in 2022 vs 36.01% in 2023.
Human2026Full text read0.70
Identification of DksA as a novel pro-inflammatory mediator of &lt;i&gt;Pseudomonas aeruginosa&lt;/i&gt; under conditions mimicking chronic cystic fibrosis lung infection.
FindingNot reported in abstract.
In vitro2026Full text read0.70
STARD10 promotes progression of HER2+ breast cancer and intracellular lipid metabolism via the cAMP/PKA/CREB1 signaling axis.
FindingNot reported in abstract.
In vitro2026Full text read0.70
Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice.
FindingNot reported in abstract.
Animal2022Full text read0.70

What people are saying

anecdotal · not evidence

Unverified first-hand accounts from public forums. These are not studies: nobody checked what was taken, whether it was what the label said, or what else was going on. They count for nothing in the evidence grade above and are shown because a reader searching 5-amino-1MQ will meet them anyway, and meeting them next to a graded evidence base is better than meeting them alone.

Community collection has not run yet, so this is an empty shelf rather than a quiet one — nothing has been read, and no conclusion about how much 5-amino-1MQ is discussed should be drawn from it.